SCHEMBL29393230

SCHEMBL29393230

O=[N+]([O-])c1ccc(Cl)nc1Nc1ccc2[nH]cnc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR4 P22455 3/20 0.47
▸ HSF1 Q00613 1/20 0.45
▸ BRD4 O60885 2/20 0.44
▸ MAPT P10636 4/20 0.43
▸ RPS6KB2 Q9UBS0 2/20 0.42
▸ FGFR1 P11362 1/20 0.41
▸ FGFR2 P21802 1/20 0.41
▸ FGFR3 P22607 1/20 0.41
▸ PIN1 Q13526 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ NAMPT P43490 1/20 0.40
▸ XDH P47989 1/20 0.40
▸ CDK1 P06493 5/20 0.40
▸ POLB P06746 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ ADRA2A P08913 1/20 0.37
▸ ADRA2C P18825 1/20 0.37
▸ ADRA1D P25100 1/20 0.37
▸ ADRA1A P35348 1/20 0.37
▸ ADRA1B P35368 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21672282 1.00 FGFR4 (0.47) FGFR4HSF1BRD4MAPTRPS6KB2
SCHEMBL21672280 0.78 FGFR4 (0.51) FGFR4HSF1BRD4MAPTRPS6KB2
SCHEMBL29394299 0.78 FGFR4 (0.51) FGFR4HSF1BRD4MAPTRPS6KB2
SCHEMBL6789738 0.78 HSF1 (0.72) FGFR4HSF1MAPTPOLBEGFR
SCHEMBL22719050 0.76 MAPT (0.54) FGFR4HSF1MAPTRPS6KB2FGFR1
SCHEMBL29535826 0.76 MAPT (0.54) FGFR4HSF1MAPTRPS6KB2FGFR1
SCHEMBL6789725 0.75 HSF1 (0.59) FGFR4HSF1MAPTPIN1CYP3A4
SCHEMBL9984822 0.75 FGFR4 (0.52) FGFR4HSF1BRD4MAPTRPS6KB2
SCHEMBL9984336 0.74 MAPT (0.52) FGFR4HSF1MAPTRPS6KB2FGFR1
SCHEMBL29392511 0.74 FGFR4 (0.54) FGFR4HSF1BRD4MAPTRPS6KB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12528810-B2 Small molecule inhibitors of DYRK/CLK and uses thereof ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2026-01-20 — — US disclosed
US-20250051325-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2025-02-13 — — US disclosed
US-12054483-B2 Small molecule inhibitors of DYRK/CLK and uses thereof ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2024-08-06 — — US disclosed
US-20220041590-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2022-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528810-B2 Small molecule inhibitors of DYRK/CLK and uses thereof CLK3, CLK2, CLK1 FGFR4 1103/4885HSF1 2370/4885BRD4 293/4885
US-20220041590-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK1, CLK3 FGFR4 1415/4885HSF1 2855/4885BRD4 356/4885
US-12054483-B2 Small molecule inhibitors of DYRK/CLK and uses thereof CLK2, CLK1, CLK3 FGFR4 1415/4885HSF1 2855/4885BRD4 356/4885
US-20250051325-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK1, CLK3 FGFR4 1415/4885HSF1 2855/4885BRD4 356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback